(Q46387602)

21 December 2017

title

Transurethral Hyperthermia for Benign Prostatic Hyperplasia: Preliminary Clinical Results (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

30 October 2022

main subject

prostatic hypertrophy

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

30 October 2022

author name string

M. D. Sapozink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691792

30 October 2022

S. D. Boyd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691792

30 October 2022

M. A. Astrahan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691792

30 October 2022

G. Jozsef

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691792

30 October 2022

Z. Petrovich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691792

30 October 2022

language of work or name

English

0 references

publication date

1 May 1990

1 reference

21 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0022534717401467?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

https://api.elsevier.com/content/article/PII:S0022534717401467?httpAccept=text/plain

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2940146-7

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

30 October 2022

1 reference

21 December 2017

volume

143

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

944-9; discussion 949-50

1 reference

21 December 2017

New approaches for the treatment of prostatic hypertrophy and cancer

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

A population-based study of prostatectomy: outcomes associated with differing surgical approaches

30 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

3-year followup of urinary symptoms after transurethral resection of the prostate

30 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Urological operations in the United States: 1979 to 1984

30 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases.

30 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Prostatectomy and sexual function

30 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Significance of the extent of transurethral prostatic resection for postoperative complications.

30 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters

30 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

30 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia

30 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

30 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Balloon dilatation for prostatic obstruction. Long-term follow-up.

30 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Microwave applicators for localized hyperthermia treatment of cancer of the prostate

30 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Local hyperthermia of the prostate gland for the treatment of benign prostatic hypertrophy and urinary retention. A preliminary report

30 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Microwave applicator for transurethral hyperthermia of benign prostatic hyperplasia

30 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

The accuracy of temperature measurement from within an interstitial microwave antenna

30 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Thermal dose determination in cancer therapy

30 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Importance of minimum tumor temperature in determining early and long-term responses of spontaneous canine and feline tumors to heat and radiation

30 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Introduction to hyperthermia device evaluation

30 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Controversies about indications for transurethral resection of the prostate.

30 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy

30 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Sexual life following 'minimal' and 'total' transurethral prostatic resection

30 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy

30 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Prazosin in the Treatment of Prostatic Obstruction A Placebo-controlled Study

30 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

The effects of driving frequency and antenna length on power deposition within a microwave antenna array used for hyperthermia.

30 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

Implantable helical coil microwave antenna for interstitial hyperthermia

30 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)40146-7

30 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1691792

30 October 2022

1 reference

21 December 2017